Skip Ribbon Commands
Skip to main content

BMT Pharmacists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Meetings   /   TCT | Transplantation and Cellular Therapy Meetings   /   BMT Pharmacists
  • Print
  • Share

 BMT Pharmacists Agenda


Don't miss the first annual BMT Tandem Meetings Clinical Practice Forum Saturday, February 19 from 8:15 AM - 3:00 PM with sessions designed for all allied health professionals across roles and disciplines to address clinically relevant topics.


8:30-8:45 AM    Welcome and Overview

8:45-9:30 AM    Post-Transplant Lymphoproliferative Disorder Following HSCT
                           - Laura Wiggins, PharmD

9:30-9:45 AM  ~ Break ~

9:45-11:15 AM   Evidence-Based Approaches to Acute GVHD: Beyond
                         Steriods and Symptom Management (part of the
                          Multidisciplinary Clinical Practice Forum)
- Vincent Ho, MD
                           - Bonnie Dirr, RN, NP

11:15-12:00 PM  Post-HSCT Relapse Treatment Strategies (part of
                            the Multidisciplinary Clinical Practice Forum)
- Michael Bishop, MD

12:00-12:15 PM  Clinical Practice Forum Audience Response System Questions

12:30-1:30 PM    Symposium

1:45-2:45 PM      Liver toxicity of chemotherapy 
- George McDonald, MD

2:45-3:00 PM      ~ Break ~

3:00-4:00 PM     American Society of Hematology 2010 Meeting Update 
- Helen Leather, BPharm

4:00-5:00 PM     Selection of Conditioning Regimens  for Autologous HSCT
                          for Lymphoma and the Role of Maintenance Therapy in
                           - Joseph McGuirk MD
                           - Casey Williams, PharmD


8:30-9:30 AM      Use of Tyrosine Kinase Inhibitors Following HSCT
                           - Nelson Cha, MD, MBA
                           - Joseph Bubalo, PharmD

9:30-10:30 AM    Research Presentations (15 min x 4 best pharmacy abstracts)

                          Optimizing the Role of Tacrolimus by Achieving and 
                          Maintaining Target Levels via a Loading Dose Followed by a
                          Maintenance Dose at Emory Healthcare

                           - Donald Hutcherson, BSc, PharmD
                          Characterization of Busulfan Dose in Hematopoietic Stem Cell
                          Transplant Patients Less than 12 Months of Age

                           - Susanne Liewer, PharmD
                          Retrospective Analysis of Effectiveness of Veno-Occlusive
                          Prophylaxis Guidelines Implemented for Patients Receiving
                          Hematopoietic Stem Cell Transplantation
                           - Hong Yen Ng, BCc, PharmD
                          Relationship Between Clearance of Intravenous Calcineurin 
                          Inhibitors and Area Under the Concentration -Time Curve 
                          Decreases During the Switch From Continuous Intravenous 
                          Infusion to Oral Administration After Allogeneic Hematopoietic 
                          Stem Cell Transplantation

                           - Daisuke Watabe, PharmD

10:30-10:45 AM   ~ Break ~

10:45-11:30 AM   Hematopoietic Cell Transplantation - Burden of Morbidity 
                           - Smita Bhatia, MD
11:30-12:15 PM   How I Treat (and Prevent) HHV-6/RSV in HSCT Recipients
                           - Angela Campbell, MD                

12:30-1:30 PM    Symposium

1:45-2:45 PM      Multiple Myeloma
Early Transplant vs. Novel Agents (No Transplant Upfront)
                           - Kamakshi Rao, PharmD
                            Maintenance Therapy Following Autologous HSCT for 
                             Multiple Myeloma
                           - Michael Westmoreland, PharmD

2:45-3:00 PM     ~ Break ~

3:00-3:45 PM     How I Treat …... in HSCT Recipients 
                           - Julianna Burzynski, PharmD
                           - LeAnne Kennedy, PharmD

3:34-4:00 PM      NMDP System Capacity Initiative
                           - Helen L. Leather, PharmD
4:00-5:00 PM      Immunizations Post-HCT: Guideline Updates and Supporting

                           - Tracey Walsh-Chocolaad, PharmD

Last Updated: 5/18/2015 6:28 PM